Mesothelioma Trends in the United States: An Update Based on Surveillance, Epidemiology, and End Results Program Data for 1973 through 2003

American Journal of Epidemiology

Volumn 159, Issue 2, 2004, Pages 107-112

  Price, Bertram ^a   Ware, Adam ^a  

^a Price Associates Inc   (United States)

Author keywords

Asbestos; Incidence; Mesothelioma

Indexed keywords

ASBESTOS; DISEASE PREVALENCE; EPIDEMIOLOGY; HEALTH MONITORING;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CHILD; COHORT ANALYSIS; COMPARATIVE STUDY; CONFIDENCE INTERVAL; DATA BASE; EPIDEMIOLOGICAL DATA; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MAXIMUM LIKELIHOOD METHOD; NEWBORN; PERITONEUM MESOTHELIOMA; PLEURA MESOTHELIOMA; POPULATION RESEARCH; REGISTER; SEX DIFFERENCE; SEX RATIO; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ASBESTOS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MESOTHELIOMA; MIDDLE AGED; RISK FACTORS; SEER PROGRAM; SEX FACTORS; UNITED STATES;

NORTH AMERICA; UNITED STATES;

EID: 0347093576     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/aje/kwh025     Document Type: Article

References (33)

1. Greenberg AK, Lee TC, Ross WN. The North American experience with mesothelioma incidence. In: Robinson BWS, Chahinian AP, eds. Mesothelioma. London, United Kingdom: Martin Dunitz Ltd, 2002.
2. Segura O, Burdorf A, Looman C. Update of predictions of mortality from pleural mesothelioma in the Netherlands. Occup Environ Med 2003;60:50-5.
3. Hemminki K, Li X. Mesothelioma incidence seems to have leveled off in Sweden. Int J Cancer 2003;103:145-6.
4. White C. Annual deaths from mesothelioma in Britain to reach 2000 by 2010. BMJ 2003;326:1417.
5. SEER 1973-2000 public-use data. Bethesda, MD: National Cancer Institute, Division of Cancer Control & Population Sciences, Surveillance Research Program, Cancer Statistics Branch, released April 2003, based on the November 2002 submission. (www.seer.cancer.gov/publicdata).
6. Aptech Systems, Inc. GAUSS mathematical and statistical system, version 4.0. Maple Valley, WA: Aptech Systems, Inc.
7. Price B. Analysis of current trends in United States mesothelioma incidence. Am J Epidemiol 1997;145:211-18.
8. Ries LAG, Eisner MP, Kosary CL, et al, eds. SEER cancer statistics review, 1975-2000. Bethesda, MD: National Cancer Institute. (http://seer.cancer.gov/csr/1975_2000/, 2003).
9. About SEER. Background discussion. Bethesda, MD: National Cancer Institute, Division of Cancer Control & Population Sciences, Surveillance Research Program. (http://seer.cancer.gov/about/).
10. SEER registries. Registries discussion. Bethesda, MD: National Cancer Institute, Division of Cancer Control & Population Sciences, Surveillance Research Program. (http://seer.cancer.gov/registries/).
11. Wun LM, Merrill RM, Feuer EJ. Estimating lifetime and age-conditional probabilities of developing cancer. Lifetime Data Anal 1998;4:169-86.
12. SEER*tat database: mortality - all COD, public-use with state, total U.S. (1969-2000). Bethesda, MD: National Cancer Institute, Division of Cancer Control & Population Sciences, Surveillance Research Program, Cancer Statistics Branch, released April 2003. (http://seer.cancer.gov). (Underlying mortality data provided by the National Center for Health Statistics (Hyattsville, MD) (www.cdc.gov/nchs)).
13. SEER*tat database: mortality - all COD, public-use with state, total U.S. (1969-2000). Bethesda, MD: National Cancer Institute, Division of Cancer Control & Population Sciences, Surveillance Research Program, Cancer Statistics Branch, released April 2003. (http://seer.cancer.gov). (Underlying mortality data provided by the National Center for Health Statistics (Hyattsville, MD) (www.cdc.gov/nchs)).
14. National Center for Health Statistics. Death rates for selected causes by 10-year age groups, race, and sex: death registration states, 1900-32, and United States, 1933-98. (http://www.cdc.gov/nchs/datawh/statab/unpubd/mortabs/hist290.htm).
15. Ventura SJ, Hamilton BE, Sutton PD. Revised birth and fertility rates for the United States, 2000 and 2001. Natl Vital Stat Rep 2003;51:1-18.
16. Selikoff IJ, Lee DH. Asbestos and disease. New York, NY: Academic Press, 1978.
17. Peto J, Henderson BE, Pike MC. Trends in mesothelioma incidence in the United States and the forecast epidemic due to asbestos exposure during World War II. Banbury report 9: quantification of occupational cancer. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1981:51-69.
18. Spirtas R, Heineman EF, Bemstein L, et al. Malignant mesothelioma: attributable risk of asbestos exposure. Occup Environ Med 1994;51:804-11.
19. Talerman A, Montero JR, Chilcote RR, et al. Diffuse malignant peritoneal mesothelioma in a 13-year-old girl. Report of a case and review of the literature. Am J Surg Pathol 1985;9:73-80.
20. Nascimento AG, Keeney GL, Fletcher CD. Deciduoid peritoneal mesothelioma. An unusual phenotype affecting young females. Am J Surg Pathol 1994;18:439-45.
21. Orosz Z, Nagy P, Szentirmay Z, et al. Epithelial mesothelioma with deciduoid features. Virchows Arch 1999;434:263-6.
22. Shanks JH, Harris M, Banerjee SS, et al. Mesotheliomas with deciduoid morphology: a morphologic spectrum and a variant not confined to young females. Am J Surg Pathol 2000;24:285-94.
23. Ordonez NG. Epithelial mesothelioma with deciduoid features: report of four cases. Am J Surg Pathol 2000;24:816-23.
24. Gloeckner-Hofmann K, Zhu XZ, Bartels H, et al. Deciduoid pleural mesothelioma affecting a young female without prior asbestos exposure. Respiration 2000;67:456-8.
25. Puttagunta L, Vriend RA, Nguyen GK. Deciduoid epithelial mesothelioma of the pleura with focal rhabdoid change. Am J Surg Pathol 2000;24:1440-3.
26. Henley JD, Loehrer PJ Sr, Ulbright TM. Deciduoid mesothelioma of the pleura after radiation therapy for Hodgkin's disease presenting as a mediastinal mass. Am J Surg Pathol 2001; 25:547-8.
27. Reis-Filho JS, Pope LZ, Milanezi F, et al. Primary epithelial malignant mesothelioma of the pericardium with deciduoid features: cytohistologic and immunohistochemical study. Diagn Cytopathol 2002;26:117-22.
28. Serio G, Scattone A, Pennella A, et al. Malignant deciduoid mesothelioma of the pleura: report of two cases with long survival. Histopathology 2002;40:348-52.
29. Peterson JT, Greenberg DS, Buffler PA. Non-asbestos-related malignant mesothelioma: a review. Cancer 1984;54:951-60.
30. Carbone M, Fisher S, Powers A, et al. New molecular and epidemiological issues in mesothelioma: role of SV40. J Cell Physiol 1999;180:167-72.
31. Stratton K, Almario DA, McCormick MC, eds. Immunization safety review: SV40 contamination of polio vaccine and cancer. Immunization Safety Review Committee. Washington, DC: National Academies Press, 2002.
32. Strickler HD, Goedert JJ, Devesa SS, et al. Trends in U.S. pleural mesothelioma incidence rates following simian virus 40 contamination of early poliovirus vaccines. J Natl Cancer Inst 2003;95:38-45.
33. Kerrigan SA, Tumnir RT, Clement PB, et al. Diffuse malignant epithelial mesotheliomas of the peritoneum in women: a clinicopathologic study of 25 patients. Cancer 2002;4:378-85.